Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial - Albers, G W; von Kummer, R; Truelsen, T (Lancet Neurol, 2015)
, et al; DIAS-3 Investigators.